Efficacy and Safety of the Anti-COVID-19 Antibody SA55 for Injection in Patients With Hematological Disorders Who Are Persistently Positive for COVID-19

NCT05675943 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Hematological Disorders
COVID-19

Interventions

BIOLOGICAL: Anti-COVID-19 Antibody SA55 for Injection

Sponsor

Beijing Boren Hospital